DDIT3 and cancer: Certain previous studies have revealed that the drug-induced sensitization of cancer cells to TRAIL occurs through the upregulation of TRAIL receptors, especially DR5, which is mediated by the ER stress-induced transcription factor CHOP [19, 28, 29].